Title : Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses.

Pub. Date : 2012 Sep

PMID : 22269178






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The International Adjuvant Lung Trial (IALT)-Bio study previously suggested ERCC1 and MSH2 as predictive of cisplatin-based therapeutic benefit. Cisplatin mutS homolog 2 Homo sapiens